The significantly lower levels of IL-1β in the CRC group (Figure 1A) could be due to the overall immunological state of the patients and the predominant processes of immune response suppression or exhaustion, as could be suggested based on the data in the next subsection. This evidence concerns the gene IL1B and colorectal carcinoma.